Outcomes of MIS-C patients treated with anakinra: a retrospective multicenter national study

BACKGROUND: The treatment of multisystem inflammatory syndrome in children unresponsive to first-line therapies (IVIG and/or steroids) is challenging. The effectiveness of IL-1 receptor antagonist, anakinra, is debated. PATIENTS AND METHODS: We conducted an anonymous retrospective multicenter study...

Descripción completa

Detalles Bibliográficos
Autores principales: Licciardi, Francesco, Covizzi, Carlotta, Dellepiane, Marta, Olivini, Nicole, Mastrolia, Maria Vincenza, Lo Vecchio, Andrea, Monno, Viviana, Tardi, Maria, Mauro, Angela, Alessio, Maria, Filocamo, Giovanni, Cattalini, Marco, Taddio, Andrea, Caorsi, Roberta, Marseglia, Gian Luigi, La Torre, Francesco, Campana, Andrea, Simonini, Gabriele, Ravelli, Angelo, Montin, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478576/
https://www.ncbi.nlm.nih.gov/pubmed/37675397
http://dx.doi.org/10.3389/fped.2023.1137051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478576/
https://www.ncbi.nlm.nih.gov/pubmed/37675397
http://dx.doi.org/10.3389/fped.2023.1137051

Ejemplares similares